A new era of blood cancer research
Each year, over 2,000 British Columbians are diagnosed with blood cancer. BC Cancer is looking at innovative treatment solutions to reduce the burden of cancer in B.C. and beyond.
News
Dr. Connie Eaves receives the 2019 Canada Gairdner Wightman Award
The Canada Gairdner Awards recognize the world's most creative and accomplished biomedical scientists who are advancing humanity and the world.
A MSE Research Grant awarded to Dr. Peter Lansdorp by the National Institute of Standards and Technology (US) to generate Strand-seq data on human reference samples
Reference collections of human genomes are a critically important resource for biomedical discovery. We recently described that the single cell Strand-seq method, which was developed in my laboratory, has unique potential to detect large polymorphic inversions and map them onto fully phased genome assemblies.
Artem Babaian (Mager Lab defendes his PhD thesis entitled “Endogenous Retroviruses Drive Transcriptional Innovation in Human Cancer”
Congratulations to Artem Babaian from the Mager Lab, who successfully defended his PhD thesis entitled “Endogenous Retroviruses Drive Transcriptional Innovation in Human Cancer” on July 30, 2019.
Congratulations to Tabea Stephan (Hoodless Lab) on receiving a Stem Cell Network 2019 Till & McCulloch Meetings travel award.
Tabea has been awarded this competitive Stem Cell Network travel award to attend the 2019 Till & McCulloch Meetings (TMM2019) and present her work on deciphering epigenetic dynamics during in vitro hepatocyte differentiation. TMM2019 will be held in Montréal, Québec, November 4-6, 2019.
Outstanding Trainee Publications 2018
The Office of the VP, Research held a Publication Awards competition for papers of outstanding scientific merit first-authored by BC Cancer students, residents, post-doctoral fellows and graduate students for work performed at, or in collaboration with, BC Cancer during 2018.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.